Revenue ($USD) : $18,449,000,000
R&D spend : $1,454,000,000.00
Employees : 51,000
Fiscal year end : 12/31/22
CEO : Kevin Lobo
Stryker’s popular Mako robotic surgery systems are more than just a robot when it comes to knee and hip surgeries. They also offer preoperative data modeling and planning, plus software and displays that assist the surgeon with navigation during the surgery.
On top of that, Stryker is tapping health data and artificial intelligence (AI) to improve surgical robotics outcomes. The idea is that data collection and analysis can help surgeons personalize procedures for individual patients to improve outcomes. Stryker plans to expand the reach of Mako even more next year with new spine and shoulder applications.
“There are no robots in total shoulders right now. When that gets released, that runway is so large. There are so many different things we could do in shoulders with the existing Mako platform,” Robert Cohen, president of Digital, Robotics and Enabling Technologies at Stryker, told MDO in January.
In light of Street-beating Q2 results, Stryker has raised its full-year 2023 outlook, predicting net sales growth within the 9.5% to 10.5% range. –CN
The goal of Stryker's Mako robotic-arm assisted surgery is to provide more predictable outcomes. [Image courtesy of Stryker]